Patient
SITE011-0146
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE011 (ITA) (Dr. Jansen)
consented 2026-02-14
Adverse events
8
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 8
Grade 1 Asthenia — outcome: RECOVERED/RESOLVED; onset 2023-03-12 (study day 196); relationship: not assessed
Grade 2 Anaemia — outcome: RECOVERED/RESOLVED; onset 2023-03-11 (study day 195); relationship: NOT RELATED
Grade 2 Constipation — outcome: RECOVERED/RESOLVED; onset 2023-03-08 (study day 192); relationship: NOT RELATED
Grade 2 Stomatitis — outcome: RECOVERED/RESOLVED; onset 2023-03-07 (study day 191); relationship: not assessed
Grade 1 Stomatitis — outcome: RECOVERED/RESOLVED; onset 2023-01-24 (study day 149); relationship: not assessed
Grade 2 Anaemia — outcome: UNKNOWN; onset 2022-10-20 (study day 53); relationship: not assessed
Grade 2 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2022-10-15 (study day 48); relationship: not assessed
Grade 2 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2022-09-28 (study day 31); relationship: not assessed
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.